Cardio-oncology: an ongoing evolution. - Wikidata - awgldk - TriplyDB

Cardio-oncology: an ongoing evolution.

Cardio-oncology: an ongoing evolution.

http://www.wikidata.org/entity/Q38551766

about

Cardio-oncology: a special focus issue from Future Oncology.

P2860

Q48429343-FA8B79A9-01FB-4969-AF7C-B8C124AB967B

P2860

Cardio-oncology: an ongoing evolution.

http://www.wikidata.org/entity/Q38551766

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Cardio-oncology: an ongoing evolution.

@en

type

label

Cardio-oncology: an ongoing evolution.

@en

prefLabel

Cardio-oncology: an ongoing evolution.

@en

P1433

Q38551766-2059B7BD-7B6C-4223-BFC7-BF4A1C1E29B8

P1476

Q38551766-781EEFA2-3105-4AFA-8DF4-4B6E2C8C44B6

P2093

Q38551766-436E135A-DD2A-44AE-8A7B-EB6F3F40C550

Q38551766-5C38BAA5-9300-4D02-8AE4-4EA7C4D23670

Q38551766-B019B63F-1C32-4F59-9669-48954358A563

Q38551766-F3EBE248-B929-4B07-BBF9-7925E3355F0A

P2860

Q38551766-013C3258-6DA2-47E5-A7F6-9F74318AAF02

Q38551766-02A4F665-5B4F-4404-BED1-20E6280CCDCA

Q38551766-038BD683-A1B2-4766-A068-E0432E81A166

Q38551766-0A594E4E-5C8E-4CB8-8FCB-99D3884BCFDB

Q38551766-0C3FB7BE-7652-4F62-8E60-A75623ABBF13

Q38551766-1ED07245-C935-4818-815C-FE6686C1E47D

Q38551766-1F25E577-0111-4101-8124-35B415F70189

Q38551766-23A68022-C792-4642-8BD9-DE48F1A45660

Q38551766-2AFF9BE0-C4F7-48D6-8F0D-A940A72454A0

Q38551766-3ACB2182-2DDF-47BC-89D0-773A9B289CB4

P304

Q38551766-57664DC4-D888-422B-AEDC-032CAAB55F00

P31

Q38551766-2C34FC46-C001-4724-8493-EC6DA02FD2C4

P356

Q38551766-A020B580-9E3C-4B19-8AD8-FADE8D9E15CF

P407

Q38551766-1248428D-4342-47F7-A327-07E81B1814E6

P433

Q38551766-77BC11DA-9CE9-41BF-A0F5-1F8A29003050

P478

Q38551766-BD46FC14-80CD-4E21-84B5-2A95CE8711A2

P50

Q38551766-B357A68F-3B03-4ADD-988A-D48DC646ACA9

P577

Q38551766-A3856FA4-4B0C-4344-B4C8-E4E6C6D062FE

P698

Q38551766-73725D93-AD5B-4A9E-B36B-A93868ACE506

P356

P1433

Future Oncology

P1476

Cardio-oncology: an ongoing evolution

@en

P2093

Bradley J Petek

http://www.w3.org/2001/XMLSchema#string

Chris Greenman

http://www.w3.org/2001/XMLSchema#string

Joerg Herrmann

http://www.w3.org/2001/XMLSchema#string

Michael S Ewer

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiac toxicity in cancer survivors

Evaluation and management of patients with heart disease and cancer: cardio-oncology

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: de

Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility

Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy

Cancer therapy-induced cardiotoxicity: basic mechanisms and potential cardioprotective therapies.

Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy.

Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy.

American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants.

Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy.

P304

2059-2066

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON.15.89

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26198836

http://www.w3.org/2001/XMLSchema#string